Mondelez International, Inc. (MDLZ): debt financing — Mondelēz enters $1.5B 364-day revolver; terminates prior $1.5B facility

Mondelez International, Inc.

New $1.5B senior unsecured 364-day revolving credit facility dated Feb 18, 2026, terminating Feb 17, 2027.
Interest at SOFR or base rate plus margin based on long-term debt ratings; facility fee 0.035%–0.090%.
Covenant requires minimum shareholders' equity of $25.0B (excluding AOCI and pension mark-to-market).
Prior $1.5B 364-day revolving credit agreement dated Feb 19, 2025 terminated upon entry.
Facility supports general corporate purposes, working capital, and commercial paper program.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Mondelez International, Inc. incurred revolving credit of $1.5 billion with JPMorgan Chase Bank, N.A., as administrative agent at SOFR or base rate, at our election, plus an applicable margin maturing February 17, 2027.

Instrument: revolving credit
Principal: $1.5 billion
Counterparty: JPMorgan Chase Bank, N.A., as administrative agent
Rate: SOFR or base rate, at our election, plus an applicable margin
Maturity: February 17, 2027
Event: incurrence

Exact text from the filing

On February 18, 2026, we entered into a revolving credit agreement (the “364‐Day Revolving Credit Agreement”) for a 364‐day senior unsecured revolving credit facility in an aggregate principal amount of $1.5 billion with the lenders named in the 364‐Day Revolving Credit Agreement, and JPMorgan Chase Bank, N.A., as administrative agent.

View on SEC.gov

301 debt financings filed in the last 30 days. Browse all debt financings →

Mondelez International, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-009018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.